3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
68
Recurrence
7
Smoldering Multiple Myeloma
4
Neoplasms
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Immunoglobulin Light-chain Amyloidosis
2
Plasmacytoma
1
Paraproteinemias
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Plasma Cell
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Magnetic Resonance Imaging
2
Cryosurgery
2
imetelstat
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
S-Adenosylmethionine
1
Prostatectomy
1
Pluvicto
1
Observation
1
Nivolumab
1
Mammography
1
High-Intensity Interval Training
1
Hematologic Tests
1
Fluorodeoxyglucose F18
1
Exercise
1
Equipment and Supplies
1
Educational Status
1
Diagnostic Techniques and Procedures
1
Diagnosis, Computer-Assisted
1
Bupivacaine
1
Blood Specimen Collection
1
Artificial Intelligence
1
Arginine
1
Acupressure
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease
×
daratumumab
×
90 days
×
Clear all
No trials found.